Valeritas to Present at Investor Conferences in December 2016
BRIDGEWATER, N.J., Nov. 23, 2016 (GLOBE NEWSWIRE) -- Valeritas Holdings, Inc. (OTCQB:VLRX) announced today that John Timberlake, President and Chief Executive Officer and Erick Lucera, Chief Financial Officer are scheduled to present at two investor conferences in December 2016.
| Event: | The Benchmark Company Micro Cap Discovery One-on-One Conference | |||||||
| Format: | One-on-One Meetings | |||||||
| Date: | Thursday, December 1, 2016 | |||||||
| Location: | Chicago, IL | |||||||
| Event: | LD Micro Main Event | |||||||
| Format: | Presentation and One-on-One Meetings | |||||||
| Date: | Wednesday, December 7, 2016 | |||||||
| Time: | 9:30 a.m. PST | |||||||
| Location: | Bel Air, CA | |||||||
About Valeritas Holdings, Inc.
Valeritas is a commercial-stage medical technology company focused on developing innovative technologies to improve the health and quality of life of people with Type 2 diabetes. Valeritas’ flagship product, V-Go® Disposable Insulin Delivery device, is a simple, wearable, basal-bolus insulin delivery solution for patients with Type 2 diabetes that enables patients to administer a continuous preset basal rate of insulin over 24 hours. It also provides on-demand bolus dosing at mealtimes. It is the only basal-bolus insulin delivery device on the market today specifically designed keeping in mind the needs of type 2 diabetes patients. Headquartered in Bridgewater, New Jersey, Valeritas operates its R&D functions in a state-of-the-art facility in Shrewsbury, Massachusetts. For more information, please visit www.valeritas.com.
Investor Contacts: Nick Laudico / Robert Flamm, Ph.D. The Ruth Group (646)536-7030 / 7017 IR@valeritas.com Or The Del Mar Consulting Group, Inc. Robert B. Prag, President 858-794-9500 bprag@delmarconsulting.com Media Contact: Christopher Hippolyte The Ruth Group (646)536-7023 PR@valeritas.com
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
